Ethyl 1-(2-amino-2-oxoethyl)piperidine-4-carboxylate

Catalog No. :
ACCNDF068
CAS No. :
40479-23-0
Molecular Formula :
C10H18N2O3
Molecular Weight :
214.26

IUPAC Name:ethyl 1-(2-amino-2-oxoethyl)piperidine-4-carboxylate

Ethyl 1-(2-amino-2-oxoethyl)piperidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$99.00Login to see priceInquiryInquiry
5g95%$386.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 1-(2-amino-2-oxoethyl)piperidine-4-carboxylate
IUPAC Nameethyl 1-(2-amino-2-oxoethyl)piperidine-4-carboxylate
MDL No.MFCD09837321
Molecular FormulaC10H18N2O3
Molecular Weight214.26
SMILESCCOC(=O)C1CCN(CC(N)=O)CC1
InChI KeyVCEAWSKFWLLLRE-UHFFFAOYSA-N
Synonym1-Carbamoylmethyl-piperidine-4-carboxylic acid ethyl ester;Ethyl 1-(carbamoylmethyl)piperidine-4-carboxylate;1-Carbomoylmethyl-piperidine-4-carboxylic acidethyl ester;4-Piperidinecarboxylic acid, 1-(2-amino-2-oxoethyl)-, ethyl ester
CAS No.40479-23-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACCNDF068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCNDF068 route product structure diagram
    ACCNDF06840479-23-0
Inquiry

2. ACCNDF068 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXNQ621 route compound structure diagram
    ACEXNQ621147636-76-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCNDF068 route product structure diagram
    ACCNDF06840479-23-0
Inquiry

Comments (0)